Multi Breath Nitrogen Washout (MBNW) as a Measure of Small Airway Function in Patients With Respiratory Disease

Sponsor
Bayside Health (Other)
Overall Status
Unknown status
CT.gov ID
NCT00163696
Collaborator
The Alfred (Other)
90
1

Study Details

Study Description

Brief Summary

The researchers are investigating a novel technique, the multi breath nitrogen washout technique, to measure airway changes in various respiratory diseases.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    It is well documented that there are significant ventilatory changes in respiratory diseases such as cystic fibrosis, asthma and the onset of bronchiolitis obliterans syndrome (BOS) following chronic rejection of lung transplantation. At present, we use measures such as spirometry and lung biopsies to determine the changes of airway function and disease severity. Our aim is to develop a novel technique called the multi breath nitrogen washout (MBNW) which we believe is able to measure the inhomogeneity of ventilation in both the larger airways (conductive region, generation 1 - 16) as well as the smaller airways (acinar region 17 - 23). Our belief is that these measurements are much more subtle than current techniques and will be more sensitive in measuring large and small airway changes in disease. The MBNW can also give us an insight as to which particular zones of the lung are affected in differing respiratory disease. For example, it is believed that BOS begins at the distal portion of the lung (acinar region) and proceeds towards the proximal zone (conductive). However, at present no current techniques can differentiate between damage to the acinar zone and the conductive zone or indeed accurately measure small airway (acinar zone) function. We believe the the MBNW has the capacity to do so.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    90 participants
    Observational Model:
    Defined Population
    Time Perspective:
    Other
    Official Title:
    Measurements of Inhomogeneity of the Small Airway With Patients With Cystic Fibrosis, Asthma and Bronchiolitis Obliterans Syndrome (Post Transplant) Using the Multi Breath Nitrogen Washout Technique
    Study Start Date :
    Sep 1, 2004

    Outcome Measures

    Primary Outcome Measures

      Eligibility Criteria

      Criteria

      Ages Eligible for Study:
      18 Years to 65 Years
      Sexes Eligible for Study:
      All
      Accepts Healthy Volunteers:
      No
      Inclusion Criteria:
      • Doctor diagnosed cystic fibrosis, asthma

      • Lung transplant recipient

      Exclusion Criteria:
      • Smoke history of less than 10 pack years

      Contacts and Locations

      Locations

      Site City State Country Postal Code
      1 Alfred Hospital Melbourne Victoria Australia 3004

      Sponsors and Collaborators

      • Bayside Health
      • The Alfred

      Investigators

      • Principal Investigator: Bruce Thompson, Head of Physiology Services, Alfred Hospital

      Study Documents (Full-Text)

      None provided.

      More Information

      Publications

      None provided.
      Responsible Party:
      , ,
      ClinicalTrials.gov Identifier:
      NCT00163696
      Other Study ID Numbers:
      • MBNW alfred
      First Posted:
      Sep 14, 2005
      Last Update Posted:
      Jul 26, 2007
      Last Verified:
      Sep 1, 2005

      Study Results

      No Results Posted as of Jul 26, 2007